Gamma Oryzanol for Health & Longevity

Created on 11/16/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Opus 5.5 – Audit

Gamma oryzanol, a rice bran compound sold as a supplement and licensed in Japan as a medicine, is used to lower cholesterol and ease menopausal complaints. Evidence is thin: the cholesterol effect is unconfirmed, menopausal relief lacks accessible support from inactive-comparison trials, and muscle and hormone claims have not held up consistently. Risks look mild. For health-focused adults it is a low-risk, low-certainty option whose effects, if present, appear modest. (Full Review)

Protocol

Pharmaceutical lipid regimen
300 mg/day
In three after-meal doses
Stress-related symptom regimen
10–50 mg/day
50 mg/day as the maximum for irritable bowel syndrome
Food-based regimen
30 mL/day rice bran oil
4,000–11,000 parts per million γ-oryzanol, replacing other cooking oil
Time to effect
Lipids
4–12 weeks
Measured after 4 weeks with rice bran oil, 12 weeks with 300 mg/day
Menopausal symptoms
4–8 weeks
Changes measured at 300 mg/day
Sleep
2 weeks
Measured with rice bran extract

Benefits

Contraindications
  • Pregnant or breastfeeding women
  • People with liver disease or a history of liver injury
  • Children
  • People adjusting thyroid hormone by TSH alone
Key Interactions
Theoretical (inferred from mechanism)
  • Cholesterol-lowering drugs (atorvastatin, rosuvastatin, ezetimibe): could deepen LDL reduction
  • Bile acid sequestrants (cholestyramine, colesevelam): could reduce γ-oryzanol absorption
  • Glucose-lowering drugs (metformin, glipizide, insulin): could raise low-blood-sugar risk with glipizide or insulin
  • Levothyroxine: could lead to under-dosing if TSH alone guides the dose
  • Antiplatelet drugs, anticoagulants and over-the-counter pain relievers (aspirin, clopidogrel, warfarin, ibuprofen): could add bleeding tendency
  • Supplements with additive effects (plant sterols, berberine, fish oil, ginkgo): added cholesterol lowering or antiplatelet activity
  • CYP-metabolized drugs (warfarin, simvastatin, omeprazole): altered drug levels unlikely
  • Rice bran oil and brown rice diets: raise total γ-oryzanol intake

Risk & Side Effects

  • High: [risks_high]
  • Medium: [risks_medium]
  • Low: Mild digestive, nervous-system and skin reactions; lowered TSH in hypothyroidism
  • Speculative: Promotion of lung tumors in rats; suppressed pituitary hormones

Monitoring

Marker Target Why
LDL cholesterol Below 160 mg/dL Main claimed benefit
Triglycerides Below 150 mg/dL Fell with fortified oil
HbA1c Below 5.7% Expected to change in diabetes or prediabetes
ALT and AST ALT about 7–56 U/L; AST about 10–40 U/L Label lists liver-enzyme rises
TSH 0.4–4.0 mIU/L Can be lowered in hypothyroidism
Free thyroxine Not specified in the ER Paired with TSH in thyroid disease
Home blood pressure Not specified in the ER Label lists blood-pressure rise

Cadence: Baseline before starting; lipids, liver enzymes and blood pressure at 8–12 weeks, then every 6–12 months; HbA1c at 12 weeks, then every 6 months; TSH with free thyroxine 6–8 weeks after starting in anyone taking levothyroxine

Qualitative Assessment

  • Frequency and severity of hot flashes and other menopausal complaints
  • Sleep onset, duration and morning alertness
  • Digestive comfort (nausea, bloating, bowel habit)
  • Mood, anxiety and tension
  • Training performance and recovery, for those using it in sport